Nascent Biotech NBIO Stock
Nascent Biotech Price Chart
Nascent Biotech NBIO Financial and Trading Overview
| Nascent Biotech stock price | 0.11 USD |
| Previous Close | 0.06 USD |
| Open | 0.06 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.06 - 0.06 USD |
| 52 Week Range | 0.03 - 0.45 USD |
| Volume | 20.05K USD |
| Avg. Volume | 405.44K USD |
| Market Cap | 7.29M USD |
| Beta (5Y Monthly) | -3.160211 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NBIO Valuation Measures
| Enterprise Value | 7.51M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nascent Biotech Stock Price History
| Beta (5Y Monthly) | -3.160211 |
| 52-Week Change | -75.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.45 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.16 USD |
NBIO Share Statistics
| Avg. Volume (3 month) | 405.44K USD |
| Avg. Daily Volume (10-Days) | 492.97K USD |
| Shares Outstanding | 124.49M |
| Float | 70.98M |
| Short Ratio | N/A |
| % Held by Insiders | 47.10% |
| % Held by Institutions | 0.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -192.67% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2689517 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 558.76K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 470.17K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.293 |
| Book Value Per Share (mrq) | -0.011 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1107974 USD |
| Levered Free Cash Flow (ttm) | 736.99K USD |
Profile of Nascent Biotech
| Country | United States |
| State | FL |
| City | Vero Beach |
| Address | 623 17th Street |
| ZIP | 32960 |
| Phone | 612 961 5656 |
| Website | https://www.nascentbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
Q&A For Nascent Biotech Stock
What is a current NBIO stock price?
Nascent Biotech NBIO stock price today per share is 0.11 USD.
How to purchase Nascent Biotech stock?
You can buy NBIO shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nascent Biotech?
The stock symbol or ticker of Nascent Biotech is NBIO.
Which industry does the Nascent Biotech company belong to?
The Nascent Biotech industry is Biotechnology.
How many shares does Nascent Biotech have in circulation?
The max supply of Nascent Biotech shares is 169.65M.
What is Nascent Biotech Price to Earnings Ratio (PE Ratio)?
Nascent Biotech PE Ratio is now.
What was Nascent Biotech earnings per share over the trailing 12 months (TTM)?
Nascent Biotech EPS is -0.01 USD over the trailing 12 months.
Which sector does the Nascent Biotech company belong to?
The Nascent Biotech sector is Healthcare.